Market

ACCRETION PHARMACEUTICALS LTD.

  • NSE CodeACCPLST
  • BSE Code-
  • ISININE0T8T01010
  • IndustryPharmaceuticals


Company Information

Management

Ms. Bhavika Dhaval Makadia

Co. Secretary & Compl. Officer

Mr. Harshad Nanubhai Rathod

Chief Financial Officer

Incorporation Year

18/12/2012

Registered Address

Registered Office : 29 Xcelon Ind Park 1, B/H, Intas Pharmaceuticals, Vasna Chacharvadi, Sanand,
Ahmedabad, Gujarat - 382213
Tel: 079-9714882929

Registrar Office

KFin Technologies Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Corporate News

Accretion Pharma. - Analysts/Institutional Investor M...

03-Mar-2026|6:21PM

Accretion Pharmaceuticals Limited has informed the Exchange about Schedule

Accretion Pharma - Clarification - Financial Results

19-Jan-2026|1:44PM

The Exchange has sought clarification from Accretion Pharmaceuticals Limite

Accretion Pharma has submitted to BSE the Shareholdin...

13-Jan-2026|11:11AM

As of December 2025, 73.52% is owned by Indian Promoters and 26.48% by Publ

Accretion Pharma - Action(s) taken or orders passed

07-Jan-2026|5:47PM

Accretion Pharmaceuticals Limited has informed the Exchange about Action(s)

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug72.74206.25
Aarti Drug360.803,293.02
Aarti Pharma698.856,335.62
Abbott India27,615.0058,679.95
Accent Micro340.00815.63

MF Holding

No Data Available

Board Meetings

DatePurpose
14/11/2025Quarterly Results
10/06/2025Audited Results & O..
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.